Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 60(2): 228-36, 2015 Jan 15.
Article in English | MEDLINE | ID: mdl-25301212

ABSTRACT

BACKGROUND: Infections with human parechoviruses (HPeVs) are associated with a wide range of clinical presentations in children, ranging from mild or asymptomatic infections to severe sepsis-like presentations or meningoencephalitis. METHODS: We reviewed medical records of infants admitted to 5 hospitals in New South Wales, Australia, during an outbreak of HPeV-3 infection. Data were collected on clinical presentation, laboratory markers, and outcome of infants with HPeV infection confirmed by reverse transcription polymerase chain reaction. RESULTS: We identified 118 infected infants. Most presented with an acute sepsis-like syndrome with high fever, tachycardia, poor perfusion, and severe irritability. Other common features were erythrodermic rash, abdominal distension, edema, and hepatitis. The age range of infants was 4 days to 9.5 months; 75% were <2 months old, including all but 1 of the 30 infants (25%) admitted to intensive care units (ICUs), who as a group, were significantly younger than infants not admitted to ICUs. Only 4% of evaluable cerebrospinal fluid samples had pleocytosis, but HPeV was detected in 95%. Brain magnetic resonance imaging on a small number of children demonstrated white matter changes and diffusion restriction. Sequencing of the VP1 gene confirmed HPeV-3 in all samples tested. All children recovered without ongoing complications at last follow-up. CONCLUSIONS: We report the largest series of HPeV-3 infection in infants, and the first outbreak in Australia. Infants presented with a severe sepsis-like syndrome with a high rate of ICU admissions, but all recovered from the acute infection without complications. Long-term sequelae are unknown.


Subject(s)
Disease Outbreaks , Parechovirus/isolation & purification , Picornaviridae Infections/complications , Picornaviridae Infections/epidemiology , Sepsis/pathology , Female , Humans , Infant , Infant, Newborn , Male , New South Wales/epidemiology , Parechovirus/classification , Parechovirus/genetics , Picornaviridae Infections/pathology , Picornaviridae Infections/virology , Retrospective Studies , Reverse Transcriptase Polymerase Chain Reaction , Sepsis/virology
2.
Free Radic Res ; 44(8): 843-53, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20528578

ABSTRACT

Abstract Rhabdomyolysis caused by severe burn releases extracellular myoglobin (Mb) that accumulates in the kidney and urine (maximum [Mb] approximately 50 microM) (termed myoglobinuria). Extracellular Mb can be a pro-oxidant. This study cultured Madin-Darby-canine-kidney-Type-II (MDCK II) cells in the presence of Mb and tested whether supplementation with a synthetic tert-butyl-polyphenol (tert-butyl-bisphenol; t-BP) protects these renal cells from dysfunction. In the absence of t-BP, cells exposed to 0-100 microM Mb for 24 h showed a dose-dependent decrease in ATP and the total thiol (TSH) redox status without loss of viability. Gene expression of superoxide dismutases-1/2, haemoxygenase-1 and tumour necrosis factor increased and receptor-mediated endocytosis of transferrin and monolayer permeability decreased significantly. Supplementation with t-BP before Mb-insult maintained ATP and the TSH redox status, diminished antioxidant/pro-inflammatory gene responses, enhanced monolayer permissiveness and restored transferrin uptake. Overall, bolstering the total antioxidant capacity of the kidney may protect against oxidative stress induced by experimental myoglobinuria.


Subject(s)
Antioxidants/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Flavonoids/pharmacology , Kidney/cytology , Myoglobin/pharmacology , Phenols/pharmacology , Adenosine Triphosphate/analysis , Antioxidants/chemical synthesis , Antioxidants/chemistry , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Epithelial Cells/pathology , Flavonoids/chemical synthesis , Flavonoids/chemistry , Humans , NF-kappa B/metabolism , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Phenols/chemical synthesis , Phenols/chemistry , Polyphenols , Sulfhydryl Compounds/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...